Case Study

SmartAnalyst Inc. used IBM Explorys clinical data to improve how a company markets its medications

Share this post:

SmartAnalyst and the IBM® Watson Health™ team used the IBM Explorys® data set to study the journey of more than 6,500 real-life psoriasis patients. The data revealed a tendency for patients to jump from topical remedies to injectables rather quickly, skipping oral medications. As a result, SmartAnalyst’s customer, a pharmaceutical company, is changing the way it communicates with patients and doctors.

Business Challenge
One of SmartAnalyst Inc.’s customers wanted to know more about psoriasis patients’ typical progression from topical remedies to oral medications to injectable biologic treatments.

Transformation
SmartAnalyst and the IBM Watson Health team identified over 6,500 real-world psoriasis patients and uncovered timely treatment trends in the way they progress through their treatment pathways.

More Case Study stories

No lazy summers for Watson Health: heavy on ‘a’ – action

Written by Watson Health | AI, Blog Post, Life Sciences

Personal values. Commercial pressures. These are forces that shape our jobs every day, especially for leaders in the life sciences. As individuals, we want to solve urgent problems that touch us deeply. As professionals representing growing businesses, we act on our beliefs best when they align with distinct market opportunities. The oft heard slogan of ...read more


Case study: Schneck Medical Center

Written by Watson Health | Case Study, Value-Based Care

Schneck Medical Center needed to develop a strategy to address a disproportionately high number of chronic obstructive pulmonary disease (COPD) patients in its population and reduce the associated readmissions. ...read more